| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $5.4M | +50.0% |
| SG&A Expense | $5.3M | +14.3% |
| Operating Income | -$14.2M | -73.3% |
| Interest Expense | $7K | +63.7% |
| Pre-tax Income | -$14.0M | -72.8% |
| Income Tax | -$193K | -1697.7% |
| Net Income | -$13.8M | -70.2% |
| EPS (Basic) | -$1.43 |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.9M | +562.5% |
| Current Assets | $9.0M | +396.7% |
| Total Assets | $20.1M | +32.8% |
| Current Liabilities | $1.6M | -9.2% |
| Long-term Debt | $278K | +0.0% |
| Total Liabilities | $5.6M | -32.0% |
| Stockholders' Equity | $14.6M | +108.3% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.7M | -45.9% |
| Capital Expenditures | $64K | +218.1% |
| Investing Cash Flow | -$157K | +35.8% |
| Financing Cash Flow | $17.6M | +251.8% |
| Free Cash Flow | -$10.7M | -46.4% |
| +19.2% |
| EPS (Diluted) | -$1.43 | +19.2% |